Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia, B-Cell × Diet × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Colorectal Neoplasms 2 Colonic Neoplasms 2 Triple Negative Breast Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Obesity 1 Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Motor Activity 1 Medical Oncology 1 Lymphoma 1 Leukemia, B-Cell 1 Colorectal Cancer Prevention 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1 Anastomotic Leak 1

Interventions

Cyclophosphamide 5 fludarabine phosphate 3 fludarabine 3 acalabrutinib 3 Mycophenolic Acid 3 Mesna 3 Melphalan 3 Whole-Body Irradiation 2 Tacrolimus 2 Rituximab 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Busulfan 2 Bone Marrow Transplantation 2 pirtobrutinib 1 obinutuzumab 1 idecabtagene vicleucel 1 ibrutinib 1 Vincristine 1 Stem Cell Transplantation 1 Prednisone 1 Leukapheresis 1 Filgrastim 1 Doxorubicin 1 Diet 1 ARQ531 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07487428 2026-03-23

CLL-IMPACT

Technical University of Munich

Phase NA Recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡